Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

PHASE2UnknownINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
MigraineMigraine HeadacheMigraine DisordersMigraine With AuraMigraine Without Aura
Interventions
DRUG

AST-726 Low dose

DRUG

AST-726 High dose

DRUG

AST-726 Placebo

Trial Locations (19)

5664

St Anna Hospital, Bogardeind 2, Geldrop

6532

Canisius Wilhelmina Hospital, Afdeling C02.04, Weg Door Jonkerbos 100 SZ Nimegen

7555

Ziekenhuisgroep Twente, Afdeling Neurolgie , Locatie Streekziekenhuis Midden Twente, Geerdinksweg 141, Hengelo

8000

Isala Kliniek, Groot Wezenland 20

20100

Turun Headache Center, Ltd. (Turun Paansarkykeskus Oy), Brahenkatu 11D, Turku

28100

Porin Laakerikeskus, Itsenalsyydenk. 33, Pori

33200

Headache Center, Tammertutka, Hameenkatu 18 6th Floor, Tampere

40100

Suomen Terveystalo Jyvaskyla, Jyväskylä

60220

Mediwest Research Centre Oy, Koskenalantie 16

PL23 1DT

The Fowey River Practice; Rawlings Lane, Fowey

TR18 4JH

The Alverton Practice, 7 Alverton Terrace, Penzance

PL 12 6DI

Saltash Health Centre, Saltash

CB7 5JD

The Staploe Medical Centre, Soham

BL4 9QZ

Stonehill Medical Centre, Piggot st., Farnworth BL4 9QZ Bolton

TW15 3EA

Stanwell Road Surgery, 25 Stanwell Road, Ashford

HA3 7LT

The Circle Practice/Belmont Health Centre, Harrow

PL6 7TH

Woolwell Medical Centre, Devon

KT24 6QT

The Medical Centre, Kingston ave, East Horsley

NN8 4RW

Albany House Medical Centre, 3 Queen St., Wellingborough

Sponsors
All Listed Sponsors
lead

Ariston Pharmaceuticals, Inc.

INDUSTRY

NCT00285402 - Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine | Biotech Hunter | Biotech Hunter